(Q37768961)

22 August 2017

Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

neoadjuvant chemotherapy

1 reference

O C Freedman

1

1 reference

22 August 2017

J Dodge

2

1 reference

22 August 2017

P Shaw

3

1 reference

22 August 2017

A M Oza

4

1 reference

22 August 2017

M Bernadini

5

1 reference

22 August 2017

S Klachook

6

1 reference

22 August 2017

K J Murphy

7

1 reference

22 August 2017

E Lo

8

1 reference

22 August 2017

B Rosen

9

1 reference

22 August 2017

H Mackay

10

1 reference

22 August 2017

language of work or name

English

0 references

publication date

29 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

119

1 reference

22 August 2017

1

1 reference

22 August 2017

22-25

1 reference

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Neoadjuvant chemotherapy in stage X ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Adenocarcinoma of the small intestine mistaken as a primary ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Advances in the treatment of metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Management of borderline ovarian neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

Beyond chemotherapy: targeted therapies in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.002

10.1016/J.YGYNO.2010.06.002

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference